Loading…

Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential

Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumo...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2003-05, Vol.278 (18), p.15958-15965
Main Authors: Lin, Ding-Yen, Lai, Ming-Zong, Ann, David K., Shih, Hsiu-Ming
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33
cites cdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33
container_end_page 15965
container_issue 18
container_start_page 15958
container_title The Journal of biological chemistry
container_volume 278
creator Lin, Ding-Yen
Lai, Ming-Zong
Ann, David K.
Shih, Hsiu-Ming
description Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation.
doi_str_mv 10.1074/jbc.M300387200
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73213204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925819582849</els_id><sourcerecordid>73213204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</originalsourceid><addsrcrecordid>eNqFkUtvEzEUhS0EoqGwZYm8QKhdTLA9zyxR0peUKhEUiZ3l8dzJuMzYwfaU5q_x63pDInWFsCxZtr5z7vU9hLznbMpZmX2-r_X0NmUsrUrB2Asy4axKkzTnP16SCWOCJzORVyfkTQj3DFc246_JCRf5LM9FMSF_1t4NO-id3kWj6RLGnzAYRfE5grH0bH27PKeXo9XROBuowk2v-lE77TwqnGnoV9Cwjc7TuUsUcg9qf6l39Bv8GiFE8MZu6EI9PtLoaOyAoildWe02YLHowg3KoPfZerUI53vmwnbKaqA3MdA7r2w42mILdI2N2WhU_5a8alUf4N3xPCXfLy_u5tfJcnV1M_-yTHTOipgUDNJWzErgDeNZplqVlWnLa80qKETWlG3NOWgcVdroVhVtVagMWs5Fo2eiTtNT8ungu_Xu73_kYIKGvlcW3BhkmaJUsOy_IK8QLYq94_QAau9C8NDKrTeD8jvJmdzHKjFW-RwrCj4cncd6gOYZP-aIwMcD0JlN99t4kLVxuoNBirLCwpIjWCFWHTDAeT0Y8DJoAzjpBiU6ysaZf7XwBDjuvyI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18732663</pqid></control><display><type>article</type><title>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</title><source>ScienceDirect (Online service)</source><creator>Lin, Ding-Yen ; Lai, Ming-Zong ; Ann, David K. ; Shih, Hsiu-Ming</creator><creatorcontrib>Lin, Ding-Yen ; Lai, Ming-Zong ; Ann, David K. ; Shih, Hsiu-Ming</creatorcontrib><description>Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M300387200</identifier><identifier>PMID: 12595526</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adaptor Proteins, Signal Transducing ; Animals ; Arsenic Trioxide ; Arsenicals - pharmacology ; Carrier Proteins - chemistry ; Carrier Proteins - physiology ; Co-Repressor Proteins ; COS Cells ; HeLa Cells ; Humans ; Intracellular Signaling Peptides and Proteins ; Mammary Tumor Virus, Mouse - genetics ; Molecular Chaperones ; Neoplasm Proteins - physiology ; Nuclear Proteins - chemistry ; Nuclear Proteins - physiology ; Oxides - pharmacology ; Promoter Regions, Genetic ; Promyelocytic Leukemia Protein ; Receptors, Glucocorticoid - physiology ; Transcription Factors - physiology ; Transcriptional Activation ; Tumor Suppressor Proteins</subject><ispartof>The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15958-15965</ispartof><rights>2003 © 2003 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</citedby><cites>FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021925819582849$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12595526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Ding-Yen</creatorcontrib><creatorcontrib>Lai, Ming-Zong</creatorcontrib><creatorcontrib>Ann, David K.</creatorcontrib><creatorcontrib>Shih, Hsiu-Ming</creatorcontrib><title>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation.</description><subject>Adaptor Proteins, Signal Transducing</subject><subject>Animals</subject><subject>Arsenic Trioxide</subject><subject>Arsenicals - pharmacology</subject><subject>Carrier Proteins - chemistry</subject><subject>Carrier Proteins - physiology</subject><subject>Co-Repressor Proteins</subject><subject>COS Cells</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Mammary Tumor Virus, Mouse - genetics</subject><subject>Molecular Chaperones</subject><subject>Neoplasm Proteins - physiology</subject><subject>Nuclear Proteins - chemistry</subject><subject>Nuclear Proteins - physiology</subject><subject>Oxides - pharmacology</subject><subject>Promoter Regions, Genetic</subject><subject>Promyelocytic Leukemia Protein</subject><subject>Receptors, Glucocorticoid - physiology</subject><subject>Transcription Factors - physiology</subject><subject>Transcriptional Activation</subject><subject>Tumor Suppressor Proteins</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkUtvEzEUhS0EoqGwZYm8QKhdTLA9zyxR0peUKhEUiZ3l8dzJuMzYwfaU5q_x63pDInWFsCxZtr5z7vU9hLznbMpZmX2-r_X0NmUsrUrB2Asy4axKkzTnP16SCWOCJzORVyfkTQj3DFc246_JCRf5LM9FMSF_1t4NO-id3kWj6RLGnzAYRfE5grH0bH27PKeXo9XROBuowk2v-lE77TwqnGnoV9Cwjc7TuUsUcg9qf6l39Bv8GiFE8MZu6EI9PtLoaOyAoildWe02YLHowg3KoPfZerUI53vmwnbKaqA3MdA7r2w42mILdI2N2WhU_5a8alUf4N3xPCXfLy_u5tfJcnV1M_-yTHTOipgUDNJWzErgDeNZplqVlWnLa80qKETWlG3NOWgcVdroVhVtVagMWs5Fo2eiTtNT8ungu_Xu73_kYIKGvlcW3BhkmaJUsOy_IK8QLYq94_QAau9C8NDKrTeD8jvJmdzHKjFW-RwrCj4cncd6gOYZP-aIwMcD0JlN99t4kLVxuoNBirLCwpIjWCFWHTDAeT0Y8DJoAzjpBiU6ysaZf7XwBDjuvyI</recordid><startdate>20030502</startdate><enddate>20030502</enddate><creator>Lin, Ding-Yen</creator><creator>Lai, Ming-Zong</creator><creator>Ann, David K.</creator><creator>Shih, Hsiu-Ming</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>20030502</creationdate><title>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</title><author>Lin, Ding-Yen ; Lai, Ming-Zong ; Ann, David K. ; Shih, Hsiu-Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adaptor Proteins, Signal Transducing</topic><topic>Animals</topic><topic>Arsenic Trioxide</topic><topic>Arsenicals - pharmacology</topic><topic>Carrier Proteins - chemistry</topic><topic>Carrier Proteins - physiology</topic><topic>Co-Repressor Proteins</topic><topic>COS Cells</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Mammary Tumor Virus, Mouse - genetics</topic><topic>Molecular Chaperones</topic><topic>Neoplasm Proteins - physiology</topic><topic>Nuclear Proteins - chemistry</topic><topic>Nuclear Proteins - physiology</topic><topic>Oxides - pharmacology</topic><topic>Promoter Regions, Genetic</topic><topic>Promyelocytic Leukemia Protein</topic><topic>Receptors, Glucocorticoid - physiology</topic><topic>Transcription Factors - physiology</topic><topic>Transcriptional Activation</topic><topic>Tumor Suppressor Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Ding-Yen</creatorcontrib><creatorcontrib>Lai, Ming-Zong</creatorcontrib><creatorcontrib>Ann, David K.</creatorcontrib><creatorcontrib>Shih, Hsiu-Ming</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Ding-Yen</au><au>Lai, Ming-Zong</au><au>Ann, David K.</au><au>Shih, Hsiu-Ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2003-05-02</date><risdate>2003</risdate><volume>278</volume><issue>18</issue><spage>15958</spage><epage>15965</epage><pages>15958-15965</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Daxx has been reported to function as a transcriptional modulator in the nucleus. In the present study, we have explored the role of Daxx in regulating the transcriptional activity of the glucocorticoid receptor (GR). Overexpression of Daxx suppressed GR-mediated activation of the mouse mammary tumor virus promoter in COS-1, HeLa, and 293T cells. In vitro and in vivo studies revealed that Daxx could directly bind to GR. The mapping analysis further demonstrated that the C-terminal region of Daxx-(501–740) mediates the interaction and transcriptional repression of GR. The repressive effect of Daxx and Daxx-(501–740) on GR could be alleviated by co-expression of promyelocytic leukemia protein (PML). Furthermore, immunofluorescence analysis showed that overexpression of wild-type PML results in the translocation of Daxx and Daxx-(501–740) to the PML oncogenic domains (PODs). By contrast, a PML sumoylation-defective mutant failed to recruit Daxx to PODs and to reverse the Daxx repression effect on GR. Accordingly, As2O3 treatment rendered the sequestration of endogenous Daxx to the PODs, leading to an enhancement of GR transactivation in COS-1 cells. Taken together, these findings suggest that recruitment of Daxx into the subnuclear POD structures sequesters it from the GR/co-activators complex, thereby alleviating its repressive effects. Our present studies provide the important link between Daxx/PML interaction and GR transcriptional activation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12595526</pmid><doi>10.1074/jbc.M300387200</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2003-05, Vol.278 (18), p.15958-15965
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_73213204
source ScienceDirect (Online service)
subjects Adaptor Proteins, Signal Transducing
Animals
Arsenic Trioxide
Arsenicals - pharmacology
Carrier Proteins - chemistry
Carrier Proteins - physiology
Co-Repressor Proteins
COS Cells
HeLa Cells
Humans
Intracellular Signaling Peptides and Proteins
Mammary Tumor Virus, Mouse - genetics
Molecular Chaperones
Neoplasm Proteins - physiology
Nuclear Proteins - chemistry
Nuclear Proteins - physiology
Oxides - pharmacology
Promoter Regions, Genetic
Promyelocytic Leukemia Protein
Receptors, Glucocorticoid - physiology
Transcription Factors - physiology
Transcriptional Activation
Tumor Suppressor Proteins
title Promyelocytic Leukemia Protein (PML) Functions as a Glucocorticoid Receptor Co-activator by Sequestering Daxx to the PML Oncogenic Domains (PODs) to Enhance Its Transactivation Potential
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A39%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Promyelocytic%20Leukemia%20Protein%20(PML)%20Functions%20as%20a%20Glucocorticoid%20Receptor%20Co-activator%20by%20Sequestering%20Daxx%20to%20the%20PML%20Oncogenic%20Domains%20(PODs)%20to%20Enhance%20Its%20Transactivation%20Potential&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Lin,%20Ding-Yen&rft.date=2003-05-02&rft.volume=278&rft.issue=18&rft.spage=15958&rft.epage=15965&rft.pages=15958-15965&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M300387200&rft_dat=%3Cproquest_cross%3E73213204%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c506t-60e3f297e1d0144afa473f1bc08e624d7fb11ec0213dcfa6f86a4ef112dc92b33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18732663&rft_id=info:pmid/12595526&rfr_iscdi=true